BAYLOR MIRACA GENETICS LABORATORIES LLC

Baylor Miraca Genetics Laboratories LLC specializes in advanced genomic and molecular diagnostic testing services, delivering clinical-grade whole exome and whole genome sequencing, germline pharmacogenomic analysis, and microarray-based variant detection. Their technical expertise centers on high-throughput next-generation sequencing platforms, bioinformatics interpretation pipelines, and clinical reporting for rare disease diagnosis, precision medicine, and undiagnosed disease programs. The contractor distinguishes itself through its ability to process complex genomic datasets with clinical validity, integrating raw data delivery with expert interpretation and actionable reports tailored to research and patient care environments. Their work supports both diagnostic and research-grade applications in inherited disorders, pharmacogenomics, and genomic medicine. The contractor maintains consistent engagement with the Department of Health and Human Services, the Department of Veterans Affairs, and the Department of Defense, primarily providing genomic testing services for clinical research initiatives, veteran health programs, and military medical applications. For HHS, they support the Undiagnosed Diseases Program and large-scale genome sequencing efforts; for VA, they deliver germline pharmacogenomic testing to guide personalized treatment; and for DoD, they provide whole exome sequencing for diagnostic and operational health purposes. Their primary focus is in medical laboratories (NAICS 621511) and testing laboratories and services (NAICS 541380), positioning them as a specialized provider in clinical genomics and molecular diagnostics within the federal health and research sectors. They serve as a trusted partner for agencies requiring high-complexity, CLIA-validated genomic testing with rigorous analytical and reporting standards. Baylor Miraca Genetics Laboratories LLC is a privately held entity based in Houston, Texas, with no federal certifications disclosed. Their geographic presence and operational capacity are focused on delivering high-volume, high-accuracy genomic services to federal health and research missions, reinforcing their role as a niche provider in precision medicine infrastructure.